Balancing Protein Stability and Activity in Cancer: A New Approach for Identifying Driver Mutations Affecting CBL Ubiquitin Ligase Activation
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Oncogenic mutations in the monomeric Casitas B-lineage lymphoma (Cbl) gene have been found in many tumors, but their significance remains largely unknown. Several human c-Cbl (CBL) structures have recently been solved, depicting the protein at different stages of its activation cycle and thus providing mechanistic insight underlying how stability—activity tradeoffs in cancer-related proteins—may influence disease onset and progression. In this study, we computationally modeled the effects of missense cancer mutations on structures representing four stages of the CBL activation cycle to identify driver mutations that affect CBL stability, binding, and activity. We found that recurrent, homozygous, and leukemia-specific mutations had greater destabilizing effects on CBL states than random noncancer mutations. We further tested the ability of these computational models, assessing the changes in CBL stability and its binding to ubiquitin-conjugating enzyme E2, by performing blind CBL-mediated EGFR ubiquitination assays in cells. Experimental CBL ubiquitin ligase activity was in agreement with the predicted changes in CBL stability and, to a lesser extent, with CBL-E2 binding affinity. Two thirds of all experimentally tested mutations affected the ubiquitin ligase activity by either destabilizing CBL or disrupting CBL-E2 binding, whereas about one-third of tested mutations were found to be neutral. Collectively, our findings demonstrate that computational methods incorporating multiple protein conformations and stability and binding affinity evaluations can successfully predict the functional consequences of cancer mutations on protein activity, and provide a proof of concept for mutations in CBL. Cancer Res; 76(3); 561–71. ©2015 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Predicting the Functional Effect of Amino Acid Substitutions and Indels
Choi, Y., Sims, G. E., Murphy, S., Miller, J. R., & Chan, A. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046688 · Cited by 2,890
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
Forbes, S. A., Bindal, N., Bamford, S., Cole, C., Kok, C. Y., Beare, D., Jia, M., Shepherd, R., Leung, K., Menzies, A., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq929 · Cited by 2,278 · cited 2×
“We extracted 103 missense mutations for the CBL gene from the COSMIC database (15) that could be mapped to four available CBL structures in its activation cycle (Fig.”
BackgroundMethodGuerois, R., Nielsen, J. E., & Serrano, L. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00442-4 · Cited by 1,728 · cited 2×
“The FoldX software program (24) was used to estimate the unfolding free energy and to model the unfolding state.”
MethodYun, C.-H., Boggon, T. J., Li, Y., Woo, M. S., Greulich, H., Meyerson, M., & Eck, M. J. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.017 · Cited by 1,192 · cited 1×
“It is in contrast to the stability–activity tradeoff reported for EGFR and other cancer-related proteins (47), where cancer mutations may disrupt autoinhibitory interactions and activate the kinase (48, 49).”
ResultGlioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α
Zhao, S., Lin, Y., Xu, W., Jiang, W., Zha, Z., Wang, P., Yu, W., Li, Z., Gong, L., Peng, Y., et al. (2009) · Science · doi:10.1126/science.1170944 · Cited by 1,119
Structure of a c-Cbl–UbcH7 Complex
Zheng, N., Wang, P., Jeffrey, P. D., & Pavletich, N. P. (2000) · Cell · doi:10.1016/s0092-8674(00)00057-x · Cited by 839 · cited 2×
“The crystal structure of the inactive complex of CBL with E2 (UbcH7) was solved more than ten years ago (12) while the active phosphorylated CBL-E2 (UbcH5B) complex was resolved fairly recently (13).”
BackgroundFolding funnels, binding funnels, and protein function
Tsai, C., Kumar, S., Ma, B., & Nussinov, R. (1999) · Protein Science · doi:10.1110/ps.8.6.1181 · Cited by 648 · cited 1×
“K382E mutation was previously observed in Noonan syndrome and was speculated to affect CBL stability or binding (40).”
BackgroundThe Cbl interactome and its functions
Schmidt, M. H. H., & Dikic, I. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1762 · Cited by 395 · cited 2×
“At the same time, since CBL proteins can bind to activated receptor tyrosine kinases via the TKBD domain, they can serve as adaptors by recruiting downstream signal transduction components such as SHP2 and P13K (9, 10).”
BackgroundBeAtMuSiC: prediction of changes in protein–protein binding affinity on mutations
Dehouck, Y., Kwasigroch, J. M., Rooman, M., & Gilis, D. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt450 · Cited by 338
Predicting the Impact of Missense Mutations on Protein–Protein Binding Affinity
Li, M., Petukh, M., Alexov, E., & Panchenko, A. R. (2014) · Journal of Chemical Theory and Computation · doi:10.1021/ct401022c · Cited by 111 · cited 2×
“We applied our recently developed optimization protocol for minimizing wild-type and mutant structures (20).”
MethodSelf-citation
Cited by
MutaBind2: predicting the impacts of single and multiple mutations on protein-protein interactions
Zhang, N., Chen, Y., Lu, H., Zhao, F., Alvarez, R. V., Goncearenco, A., Panchenko, A. R., & Li, M. (2020) · iScience · doi:10.1016/j.isci.2020.100939 · Cited by 199
Self-citationMutaBind estimates and interprets the effects of sequence variants on protein–protein interactions
Li, M., Simonetti, F. L., Goncearenco, A., & Panchenko, A. R. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw374 · Cited by 118
Self-citationMutational signatures and mutable motifs in cancer genomes
Rogozin, I. B., Pavlov, Y. I., Goncearenco, A., De, S., Lada, A. G., Poliakov, E., Panchenko, A. R., & Cooper, D. N. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx049 · Cited by 58
Self-citationAn interpretable molecular framework for predicting cancer driver missense mutations
Yang, Y., Sun, W., Liu, Y., Zhang, J., & Li, M. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2524289123 · Cited by 3
“In 2016, we showed that integrating multiple protein conformations with stability and binding affinity assessments effectively predicts the functional impact of cancer mutations in CBL (25).”
InfluentialSelf-citation
Metadata
- Authors
- Li, M., Kales, S. C., Ma, K., Shoemaker, B. A., Crespo-Barreto, J., Cangelosi, A. L., Lipkowitz, S., & Panchenko, A. R.
- Venue
- Cancer Research
- Published
- 2016-01-31
- Volume
- 76
- Issue
- 3
- Pages
- 561-571
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2216467860
- Cited by
- 34
- References
- 10
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Balancing Protein Stability and Activity in Cancer: A New Approach for Identifying Driver Mutations Affecting CBL Ubiquitin Ligase Activation. https://app.cochat.ai/papers/10.1158/0008-5472.can-14-3812
- The paper
- Li, M., Kales, S. C., Ma, K., Shoemaker, B. A., Crespo-Barreto, J., Cangelosi, A. L., Lipkowitz, S., & Panchenko, A. R. (2016). Balancing Protein Stability and Activity in Cancer: A New Approach for Identifying Driver Mutations Affecting CBL Ubiquitin Ligase Activation. Cancer Research. https://doi.org/10.1158/0008-5472.can-14-3812
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.